Targeting Annexin A2 to Reactivate Tumor-Associated Antigens Presentation and Relieve Immune Tolerance in Liver Cancer

Scientists identified the role of Annexin A2 in the tumor-associated antigens presentation and immune evasion, which could be an actionable target in cancer immunotherapy.